Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
6th grade Good
|
|
New words:
accomplish, adenocarcinoma, ago, antibody, arm, benign, breast, breath, bronchioalveolar, call, called, clarify, comply, composition, cough, cure, diarrhea, dipeptidyl, docetaxal, dyspnea, ensure, exislund, expedite, experienced, familial, FAS, frequent, FSP, German, histology, implementation, implemented, indistinguishable, infrequent, interstitial, layoff, meaningful, median, Merck, metabolic, minimum, monotheraphy, noteworthy, objective, observed, omitted, oriented, peptidase, poor, population, predetermined, premier, prioritize, Probiodrug, promising, promulgated, Puerto, pulmonary, rash, ready, redeem, redeemable, redemption, revealed, Rico, safety, separate, sixty, size, statistical, statistically, Tarceva, team, TM, Type, UK, Union, whichever, York
Removed:
arrangement, assessment, attributable, BAC, begin, block, bronchioloalveolar, comparable, effort, encouraging, erlotinib, exciting, gemcitabine, gene, issue, kinase, label, largest, mutated, open, partnership, prominent, proprietary, protein, range, reduction, registered, safe, scale, setting, specifically, strong, tested, tolerated, transitional, tyrosine, utility, wide
Filing tables
Filing exhibits
Related press release
OSIP similar filings
External links